During the refresher course we will give a brief overview of the current state of treatment paradigms for the most common pediatric solid tumors requiring radiotherapy. We will address the pitfalls and how to avoid them during treatment planning and will review best practices. We will also review what the circumstances are in the pediatric population that help to drive the treatment decisions such as concern for late effects and adverse effects on development.
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this live activity, attendees should be able to do the following:
1. Identify current radiation related treatment approaches to pediatric brain tumors.
2. Discuss the current radiation related treatment approached to pediatric solid malignancies outside of the brain.
3. Recognize, and avoid, the common pitfalls in radiotherapy and normal tissue dosimetry in the pediatric population.
Torunn Yock, MD, MCH, FASTRO is employed by Massachusetts General Hospital and has no other disclosures to declare.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.